Quick Summary
Eligard 30mg Injection
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹19978
MRP: ₹24972.19
(You Save ₹4994.19)
1 VIAL(s)
Eligard 30mg Injection
Salt Composition
LEUPROLIDE ACETATEMarketer
EMCURE PHARMACEUTICALS LTD
Prepaid Only. Non-Returnable.
20% OFF
₹19978
MRP: ₹24,972.19
Inclusive of all taxes
20% Off
Salt Composition
LEUPROLIDE ACETATEMarketer
EMCURE PHARMACEUTICALS LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Introduction to Eligard 30mg Injection
Eligard 30 mg Injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists. Eligard injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women.
This medicine is also used for the treatment of premature puberty, which is characterised by early physical development in children due to hormonal imbalances.
Do not receive this injection if you are allergic to Eligard 30mg or its ingredients, including Goserelin and Triptorlin. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant.
During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumour.
Before starting the treatment, notify your doctor about your underlying medical conditions, such as diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or are at increased risk of thinning of bones (osteoporosis). This medicine is not recommended for patients with abnormal vaginal bleeding.
If you are a woman of childbearing age, use non-hormonal contraceptives while taking Eligard 30mg injection. Report to your doctor if you are a man with urinary obstruction or had an operation to remove your testicles. Tell your doctor if you feel pressure on the spinal cord and experience urinary disorders and haematuria (blood in the urine).
Uses of Eligard 30mg Injection
Eligard injection uses are:
- To treat prostate cancer
- Hormone-responsive breast cancer in perimenopausal (around menopause) women
- Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus)
- Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones)
Therapeutic Effects of Eligard 30mg Injection
Eligard 30mg decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.
Interaction of Eligard 30mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional and vitamin supplements, vaccines, and herbal products. Certain medications such as Quinidine, Procainamide, Amiodarone, Sotalol, Painkillers, and Antibiotics may interact with the effects of Eligard 30mg and reduce its effectiveness by causing undesirable side effects.
More Information about Eligard 30mg Injection
- Keep Eligard 30mgout of sight and reach of children.
- Store in a cool, dry place, away from direct heat and light.
- Store below 25°C
- Do not refrigerate or freeze.
How to consume Eligard 30mg Injection
Eligard 30mg injection, typically available in an Eligard ampule, is usually administered in the arm, thigh, or abdomen. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.
Safety Advice for Eligard 30mg Injection
Breast Feeding
Eligard 30mg injection is contraindicated in breastfeeding women. Inform your doctor if you are breastfeeding before taking this injection.
Alcohol
Consuming alcohol during the Eligard 30mg injection treatment may increase the risk of thinning bones (osteoporosis). Hence caution should be taken. Consult your doctor for more information.
Liver
Eligard 30mgshould be used cautiously in patients with liver impairment. Consult your doctor before receiving it. Notify your doctor about underlying liver conditions.
Lungs
It is unknown whether Eligard 30mg is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Driving
Eligard 30mg Injection can cause drowsiness, visual disturbances, or dizziness. It is unsafe; hence avoid driving if you are unwell.
Pregnancy
It is unsafe to use Eligard 30mg injection because it is contraindicated in pregnant women. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.
Side Effects of Eligard 30mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Eligard injection side effects are as follows:
Serious side effects of Eligard 30mg Injection are:
- Severe rash, itching
- Shortness or difficulty in breathing
- Cough with blood
- Pulmonary embolism
- Severe headache
Common side effects of Eligard 30mg Injection are:
- Altered blood sugar and cholesterol levels
- Injection site reactions
- Loss of appetite
- Abnormal liver function
- Swelling in the ankle or hand
- Difficulty sleeping, headache
- Mood swings, depression
- Weight changes
- Nausea, vomiting
- Vaginal dryness, bleeding
- Loss of interest in sexual intercourse
- Hot flushes
- Bone pain, muscle weakness
- Breast tenderness
Word of Advice
During the treatment of breast cancer with Eligard 30mg, it is recommended to undergo regular checkups every three months in combination with an aromatase inhibitor. Do not receive this injection if you experience any abnormal vaginal bleeding. Consult your doctor immediately if you or your child is suffering from a headache, even after treating it with painkillers, vision problems, buzzing, or ringing in the ear. If you have diabetes, ask your doctor to monitor your glucose and blood sugar levels regularly. Before starting, inform your doctor if you are still mensurating.
FAQs about Eligard 30mg Injection
Q1.
How does Eligard 30mg work?
Eligard 30mg decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.
Q2.
Who should not use Eligard 30mg?
Eligard 30mg should not be used by pregnant and breastfeeding women, people who are allergic to the medication, or people with a history of osteoporosis or bone fractures. It should also be used cautiously in people with a past of depression or mental illness.
Q3.
What should I do if I miss a dose of Eligard 30mg?
If you miss a dose of Eligard 30mg, contact your healthcare provider as soon as possible to schedule the missed dose. Do not double up on doses to make up for a missed one.
Q4.
Can Eligard 30mg cause weight gain?
Weight gain is not a common side effect of Eligard 30mg, but it may occur in some people.
Q5.
What are the common Eligard side effects associated with the Eligard 3-month dose?
Common Eligard side effects associated with the Eligard 3-month dose may include hot flashes, injection site reactions, fatigue, and changes in mood. Some individuals may also experience increased sweating, decreased libido, or pain in the bones. It’s important to discuss any side effects with your healthcare provider to ensure proper management.
Fact Box of Eligard 30mg Injection
Molecule name: Leuprolide acetate | Therapeutic class: Antineoplastics |
Pharmacological class: Gonadotropin-Releasing Hormone (GnRH) agonists | Indication: 1. Prostate cancer 2. Hormone-responsive breast cancer in perimenopausal (around menopause) women 3. Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) 4. Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones) |
References
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Introduction to Endocrinology: The hypothalamic-pituitary axis, 12th edition, 2011, 1122.
- KD Tripathi, Essentials of Medical Pharmacology, Anterior pituitary hormones, 7th edition, 2013, 243.
- Takeda UK Limited, Electronic medicines compendium (emc), [ Revised on June 2022] [ Accessed on 12th April 2023], https://www.medicines.org.uk/emc/product/4651/smpc
- Abbott Laboratories, US Food and Drug Administration, [Issued on Feb 2016] [ Accessed on 12th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020517s036_019732s041lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vijayalakshmi N.
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
